A prominent dementia research center based in Cleveland, Ohio secured $15.4 million from the National Institute on Aging, part of the National Institutes of Health (NIH). The Cleveland Alzheimer’s Disease Research Center (CADRC), led by the Cleveland Clinic secured the funds it was announced Thursday. The new injection of capital supports a multi-institution collaborative aiming to accelerate research for Alzheimer’s disease and similar dementias. The grant derives from the Alzheimer’s Disease Research Centers Program, involving 31 NIH-funded centers around America. Led by James Leverenz, MD, of the Cleveland Clinic, CADRC represents the only research center dedicated to neurodegenerative conditions in Ohio, and includes top physicians’ and scientists from the Midwestern city’s elite health and research institutions including Case Western Reserve University (CWRU), Cleveland Clinic, Louis Stokes Cleveland VA Medical Center (VA), the MetroHealth System and University Hospitals.
More than 6 million Americans are currently living with Alzheimer’s disease, according to the Alzheimer’s Association. By 2050 this number is projected to rise to 13 million. Between 2...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).